Cortical blindness is a loss of vision caused by injury to the visual parts of the brain, not the eyes. People with cortical blindness may report complete or partial vision loss, trouble recognizing objects, or missing parts of their visual field. It often starts suddenly after stroke, head injury, infection, or lack of oxygen, and recovery can vary. Many living with cortical blindness work with neuro-ophthalmology, vision rehabilitation, and occupational therapy to improve safety and daily function. The outlook depends on the cause and extent of brain injury, and some people improve over months while others have lasting changes.
Overview
Cortical blindnessSymptoms
Cortical blindness causes vision loss despite healthy-appearing eyes. It may start suddenly after a stroke or head injury. Symptoms include complete or partial blindness, trouble seeing to one side, visual confusion, and sometimes not recognizing the vision loss.
Outlook and prognosis
Many living with cortical blindness stabilize over time, and some regain limited visual function, especially if the cause is a mild stroke or injury. Early rehabilitation can improve navigation, reading strategies, and confidence. Outcomes vary with brain recovery, age, and coexisting conditions.
Causes and risk factors
Cortical blindness usually follows damage to both occipital lobes from stroke, cardiac arrest with hypoxia, severe head injury, infection, tumors, or hypertension/eclampsia. Risks include hypertension, atrial fibrillation, diabetes, clotting disorders, and older age. In infants, perinatal hypoxic‑ischemic injury causes it.
Genetic influences
Genetics plays a limited role in cortical blindness overall, which most often stems from brain injury or stroke. That said, rare inherited conditions can damage the visual cortex and increase risk. Genetic testing is considered when features suggest a hereditary disorder.
Diagnosis
Diagnosis of cortical blindness uses sudden vision loss with normal eye exam, neurologic assessment, and brain MRI or CT. Visual evoked potentials and bedside tests help confirm and exclude eye disease or other causes.
Treatment and drugs
Treatment for cortical blindness focuses on rehabilitation and maximizing remaining vision pathways. Options may include vision therapy, compensatory training (like scanning strategies), occupational therapy, and assistive technologies. Managing underlying causes, preventing further brain injury, and treating related symptoms also matter.
Symptoms
In daily life, many notice sudden, profound vision changes, often after a stroke or head injury. With cortical blindness, sight fades because the visual parts of the brain are injured, even though the eyes and pupils can seem normal. Early on, this might look like missing parts of the scene, bumping the shoulder on doorframes, or difficulty reading lines of text. Early symptoms of cortical blindness range from patchy blind spots to complete loss of vision, and they can shift as the brain heals or swelling settles.
Vision may drop quickly in both eyes, sometimes to complete darkness. There is no eye pain because the problem starts in the brain, not the eyes.
Parts of the view can be missing, often the left or right side. You might bump into objects or miss a step on the side you can’t see.
Some can tell day from night or notice bright lights but not shapes or faces. This can make busy places feel overwhelming.
Some people sense movement but cannot identify what moved. This can feel confusing when people or cars seem to appear suddenly.
How people usually first notice Cortical blindness?
Many people first notice cortical blindness after a sudden event—such as a stroke, head injury, or loss of oxygen—when vision seems “gone” or oddly fragmented even though the eyes look normal and the pupils react to light. The first signs of cortical blindness often include trouble seeing on one or both sides, bumping into objects on the affected side, difficulty recognizing faces or places, or saying they can’t see despite a normal eye exam; some also experience visual confusion or “filling in” of missing areas. This is usually how cortical blindness is first noticed: a sudden or rapidly developing change in vision tied to brain injury rather than a problem with the eyes themselves, prompting urgent evaluation.
Types of Cortical blindness
Cortical blindness affects how the brain processes vision, so eyesight problems come from the brain rather than the eyes. People may notice different sets of symptoms depending on their situation. Doctors sometimes classify symptoms as partial versus complete, temporary versus lasting, and by whether awareness of the vision loss is preserved. The early symptoms of cortical blindness can range from subtle trouble finding objects to a complete loss of sight with normal-looking eye exams.
Complete blindness
Vision is absent in both eyes even though the eyes and pupils look normal. Light may not be detected at all. People often rely on touch and hearing for navigation.
Partial loss
Some vision remains, such as islands of sight or the ability to sense light. Many have homonymous visual field loss, meaning the same side is missing in both eyes. Reading, driving, and crowd navigation are often challenging.
Anton syndrome
People deny or are unaware of their vision loss. They may confidently describe what they “see,” which can be confabulated. Safety risks increase because insight is limited.
Riddoch phenomenon
Motion can be seen while static objects are not. Moving people or cars may be detectable, but still scenes seem blank. This can help with mobility training.
Transient episodes
Vision loss comes and goes, often minutes to hours, and may follow migraine aura, seizures, or brief blood-flow changes. Between episodes, vision may return to baseline. Tracking triggers can guide prevention.
Persistent deficits
Vision loss remains stable or only slowly improves after a brain injury or stroke. Rehabilitation focuses on maximizing remaining vision and compensatory strategies. The balance of symptoms can shift over time.
Visual hallucinations
Simple flashes or complex formed images can appear, especially in low light or when tired. People usually know these are not real, but they can be distracting or distressing. Clinicians often describe them in these categories: simple (shapes, lights) versus complex (people, patterns).
Associated agnosias
Recognition problems occur despite seeing an object’s outline, like difficulty recognizing faces (prosopagnosia) or letters (alexia). Day-to-day tasks like reading labels or identifying acquaintances can be affected. Speech and memory are usually intact.
Light–dark mismatch
Pupils react normally to light, but the person cannot consciously see. Eye exams may look normal, which can feel confusing. Loved ones may recognize certain types sooner than the person experiencing them.
What genetics can tell you about symptoms
In some families, variants in genes tied to brain development or blood flow make the visual cortex vulnerable, leading to sudden or gradual loss of sight despite healthy eyes. Mitochondrial changes, like in Leber hereditary optic neuropathy, can worsen cortical damage and visual confusion.
Causes and risk factors
Cortical blindness often follows damage to the visual cortex from stroke or severe head injury.
Other causes include lack of oxygen after cardiac arrest or around birth, brain infections or inflammation, brain tumors, and surgery involving the occipital lobe.
Risk factors for cortical blindness include older age, high blood pressure, diabetes, high cholesterol, an irregular heartbeat, and smoking.
Family history of stroke or clotting problems can raise risk, and heavy alcohol or cocaine use and traumatic injuries from crashes or falls can too.
Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Environmental and biological risk factors
When the visual parts of the brain are injured, sight can be lost even though the eyes themselves are healthy. This is known as cortical blindness. Some people first notice early symptoms of cortical blindness after a stroke or head injury, when vision suddenly feels dim, patchy, or gone. Doctors often group risks into internal (biological) and external (environmental).
A clot or bleed in the back of the brain can damage the visual cortex. This kind of stroke is a leading cause of cortical blindness.
Cardiac arrest, near-drowning, or severe breathing failure can deprive the brain of oxygen. The visual cortex is highly sensitive to this and may be damaged, leading to cortical blindness.
Blows to the back of the head can bruise or swell the visual parts of the brain. Moderate to severe traumatic brain injury increases risk of cortical blindness.
Certain infections and inflammation of the brain can involve the visual areas. Swelling or injury in these regions can cause cortical blindness.
Genetic risk factors
Certain inherited conditions can increase the chance of damage to the brain’s visual centers, which can lead to cortical blindness. These include mitochondrial syndromes that trigger stroke-like episodes, genetic disorders of small blood vessels, differences in how the cortex forms, and inherited blood or metabolic diseases that affect the back of the brain. Carrying a genetic change doesn’t guarantee the condition will appear. In some families, vision loss follows a sudden event, while in others it begins early in life—patterns that can shape early symptoms of cortical blindness.
Mitochondrial stroke syndromes: Conditions such as MELAS can cause stroke-like episodes that often involve the occipital lobes. When these areas are affected, cortical blindness can develop suddenly. These changes are passed down through the maternal line and can vary widely within the same family.
Inherited small-vessel disease: Disorders like CADASIL or COL4A1-related disease make brain vessels fragile and prone to strokes or bleeds. Occipital injuries from these events can cause profound vision loss. A history of early strokes or migraines in relatives may be a clue.
Sickle cell disease: This inherited blood disorder raises stroke risk, particularly in childhood. If the stroke involves the visual cortex, permanent visual loss may occur. Risk differs by genotype, with some forms more severe than others.
Fabry disease: This X-linked condition damages small vessels and can cause strokes in the posterior circulation that feeds the visual cortex. Men tend to be more severely affected, while women may have a mix of mild and significant symptoms. Prompt diagnosis can reduce stroke risk but does not eliminate it.
Cortical malformation genes: Genetic changes that disrupt how the brain’s cortex forms (for example, lissencephaly or polymicrogyria) can involve the visual areas. Some children present with cortical visual impairment from birth, and severe involvement can meet criteria for cortical blindness. Seizures and developmental differences may occur alongside visual symptoms.
Leukodystrophies: Inherited white-matter disorders, such as adrenoleukodystrophy or metachromatic leukodystrophy, can damage the visual pathways and occipital lobes. Vision can decline over time and, in advanced stages, complete loss of vision from brain involvement may develop. Age of onset and pace vary by subtype.
Vascular malformation syndromes: Hereditary conditions like hereditary hemorrhagic telangiectasia (HHT) or familial cavernous malformations increase the chance of brain bleeds. Hemorrhage in the occipital cortex can cause sudden cortical blindness. Family patterns of nosebleeds or known brain vascular lesions may raise suspicion.
Peroxisomal disorders: Syndromes in the Zellweger spectrum and related metabolic conditions can involve the cortex and visual pathways from early infancy. Severe forms may include profound visual impairment. Genetic testing can confirm the diagnosis and guide family planning.
Lifestyle risk factors
Lifestyle habits can influence the chance of damage to the brain’s visual centers by affecting stroke risk, head trauma, and oxygen supply to the brain. In other words, how lifestyle affects cortical blindness is largely through its impact on vascular health and injury risk. Key lifestyle risk factors for cortical blindness include choices that increase the likelihood of stroke or severe head injury, and habits that reduce brain resilience.
Tobacco accelerates atherosclerosis and blood clot formation that can lead to occipital stroke. Quitting lowers stroke risk and helps protect the brain’s visual pathways.
Diets high in sodium, trans fats, and added sugars raise blood pressure and cholesterol, promoting strokes that can damage the visual cortex. Emphasizing vegetables, fruits, fiber, and unsaturated fats supports healthier cerebral blood flow.
Sedentary behavior worsens blood pressure, glucose control, and weight, all of which heighten ischemic stroke risk to the occipital lobes. Regular aerobic and strength activity improves vascular health and lowers the chance of brain injury from stroke.
Heavy or binge drinking raises blood pressure, triggers atrial fibrillation, and increases hemorrhagic stroke risk that can cause cortical blindness. Moderation or abstinence reduces these cerebrovascular threats.
Risk prevention
Cortical blindness usually follows damage to the visual areas of the brain, most often from a stroke, severe head injury, or lack of oxygen. While you can’t prevent every cause, you can lower the odds by protecting your brain and blood vessels and by acting fast if warning signs appear. Prevention can mean both medical steps, like vaccines, and lifestyle steps, like exercise. Rapid treatment for a possible stroke can also reduce the chance of permanent vision loss.
Keep blood pressure in a healthy range to reduce stroke risk, the leading cause of cortical blindness. Home monitoring and regular check-ins help you and your clinician adjust treatment over time.
Treat atrial fibrillation and other rhythm problems to prevent clots that can travel to the brain. Blood thinners or procedures may be recommended to lower stroke risk.
Manage cholesterol and blood sugar to protect brain blood vessels. Medicines like statins and healthy eating patterns together reduce the chance of a sight-threatening stroke.
Stopping tobacco lowers clotting and artery damage that can lead to brain injury and cortical blindness. Get support with counseling, nicotine replacement, or medications.
Transmission
Cortical blindness is not contagious and cannot be transferred between people. It happens when the brain’s vision centers are damaged—most often after a stroke, a lack of oxygen, head injury, or, less commonly, infections or inflammation affecting the brain—so there is no person-to-person spread. Cortical blindness is also not typically inherited; while rare genetic disorders or complications around birth can lead to brain injury and vision loss, the condition itself is not passed down in families. In short, there is no way for cortical blindness to be transmitted, and it carries no infectious risk.
When to test your genes
Consider genetic testing if cortical blindness appears early, clusters in your family, or is paired with other neurologic signs (seizures, developmental delays, movement issues). Testing can clarify cause, guide imaging and therapies, and help plan vision rehabilitation and educational supports. A genetics or neuro-ophthalmology consult can triage which tests matter.
Diagnosis
When vision suddenly or gradually goes dark while routine eye checks look normal, doctors consider brain-based causes like Cortical blindness. Doctors usually begin with a detailed history and focused exams to understand what changed and how quickly. The diagnosis of Cortical blindness rests on confirming severe vision loss with intact pupil reactions, plus brain imaging that shows injury in the visual cortex. Sometimes this is confirmed quickly; in other cases, several tests are needed.
Clinicians ask about sudden vs. gradual vision loss, headaches, stroke risk, head injury, or recent cardiac arrest. Everyday examples—like bumping into doorframes or not recognizing large objects—help clarify the pattern. This context points the team toward or away from Cortical blindness.
The front and back of the eyes usually look healthy, and pupils still react to light. Normal eye structures with profound vision loss suggest a brain cause rather than an eye disease.
Doctors look for signs of occipital lobe injury and related findings, such as confusion, visual neglect, or trouble processing what is seen. These features can accompany Cortical blindness after stroke or lack of oxygen.
Perimetry maps how much of the visual field is lost. Symmetric losses (for example, both left sides missing) support a brain origin like Cortical blindness.
Stages of Cortical blindness
Cortical blindness does not have defined progression stages. It often begins suddenly—commonly after a stroke, a drop in oxygen to the brain, or a head injury—and what happens next depends on the brain injury itself; early symptoms of cortical blindness can include abrupt vision loss even though the eyes look healthy. Different tests may be suggested to help confirm the diagnosis, including a standard eye exam, visual field testing, and brain imaging such as MRI or CT. Cortical blindness is then monitored over time with follow‑up vision checks and, when needed, input from a neuro‑ophthalmology or neurology specialist.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, and the answer depends on why cortical blindness started and how much the brain’s visual areas were affected. For some, vision remains severely limited, especially for complex scenes or recognizing what’s seen, even if the eyes themselves are healthy. Others notice partial recovery over weeks to months, often in the first 3–6 months, as swelling settles and the brain reorganizes. Everyone’s journey looks a little different.
Prognosis refers to how a condition tends to change or stabilize over time. If cortical blindness followed a stroke, heart-lung arrest, severe low blood pressure, head injury, or infection, the amount of brain injury usually shapes the outlook. Early symptoms of cortical blindness that ease within days to weeks can signal a better chance of partial improvement. Children sometimes regain more function than adults because the developing brain can rewire more easily. Mortality relates to the underlying cause (for example, large strokes or cardiac arrest), not the blindness itself; once medically stable, cortical blindness does not by itself shorten life expectancy.
With ongoing care, many people maintain independence using low-vision strategies, orientation and mobility training, and assistive tech like audio cues and screen readers, even if full sight does not return. Vision rehabilitation can also train the “islands” of seeing that remain, helping with reading, navigation, and daily tasks. Talk with your doctor about what your personal outlook might look like, including whether further brain imaging, vision therapy, or occupational therapy could help now or down the road. Genetic testing can sometimes provide more insight into prognosis when cortical blindness is part of a rare inherited brain disorder, though many cases are acquired rather than genetic.
Long-term effects
Cortical blindness can change how someone moves through the world day to day, from reading street signs to recognizing familiar places. Recovery is possible for some, especially in the first months, but lasting vision loss is common. Long-term effects vary widely, depending on the cause, size, and location of the brain injury. People may remember early symptoms of cortical blindness as a sudden loss of sight even though the eyes themselves seemed fine.
Some people regain islands of vision or clearer light perception over weeks to months. Improvements often slow after the first 6–12 months but can continue more gradually.
Blind spots or missing halves of the visual world may remain long term. These gaps can make it hard to notice obstacles, read, or navigate busy spaces.
Crowded text, small print, or scanning across lines can be exhausting. Many find they read more slowly or need larger, high-contrast fonts.
Recognizing faces in real time can be hard, especially in crowds or poor lighting. People may rely on voices, hairstyles, or clothing cues instead.
How is it to live with Cortical blindness?
Living with cortical blindness can feel disorienting at first because the eyes may be healthy while the brain’s visual processing is impaired, so what you “see” can be patchy, distorted, or absent even in familiar places. Daily life often relies more on sound, touch, and predictable routines; many use orientation and mobility training, tactile labels, and screen readers to navigate safely and stay independent. Fatigue is common from concentrating on non-visual cues, and some experience visual confusion or denial of the loss, which can be unsettling. Family, friends, and coworkers may need guidance on offering support—speaking clearly, announcing presence, reducing clutter, and being patient—as confidence grows for everyone with practice.
Treatment and drugs
Treatment for cortical blindness focuses on supporting vision function, safety, and independence while the brain heals or adapts. Although living with cortical blindness can feel overwhelming, many people manage their symptoms and live fulfilling lives. Early care usually includes vision rehabilitation, training to maximize remaining visual processing (such as scanning strategies), orientation and mobility training for safe navigation, and occupational therapy to adapt home and work tasks; assistive tools like high‑contrast cues, audio prompts, and screen readers can help day to day. If cortical blindness follows a stroke, head injury, or infection, treating the underlying cause—stabilizing blood flow, reducing brain swelling, controlling seizures, or addressing inflammation—comes first; some may also benefit from carefully guided visual restitution or compensatory therapies offered by specialized clinics. Your doctor may suggest combining rehab with prisms or tints for glare, headache management, and counseling for mood or anxiety, and regular follow‑up helps adjust the plan if vision or needs change.
Non-drug treatment
Cortical blindness can make everyday tasks—reading the mail, finding the right doorway, moving through a busy room—feel uncertain. Many people regain confidence with structured rehabilitation that builds workarounds and strengthens remaining skills. Beyond prescriptions, supportive therapies can help you navigate safely, communicate, and stay independent. Plans vary by age, cause, and how much vision is affected.
Visual rehabilitation for cortical blindness focuses on building compensatory skills and maximizing usable vision. A team helps with reading strategies, home tasks, and return-to-work plans.
Training teaches safe navigation using landmarks, auditory cues, and, when appropriate, a white cane. Practice in real settings builds confidence indoors and outdoors.
Guided exercises build systematic eye and head movements to compensate for missing visual areas. Over time this can improve reading, object finding, and wayfinding.
Special prisms shift parts of the scene from the blind side into your seeing area. Fitting and training with a neuro-vision specialist are key for real-world use.
Your genes may have an impact on how drugs work for you
Medicines used around cortical blindness—such as anticonvulsants for seizures, blood thinners after stroke, or sedatives—can work differently based on genes that control drug breakdown and brain receptors. Genetic differences may change dose needs, side‑effects, and safety monitoring.
Pharmacological treatments
There’s no single medicine that restores sight once the visual cortex is injured in cortical blindness, but medicines can treat the cause, prevent further damage, and ease related problems. What’s used depends on why vision was lost—most often stroke, but sometimes inflammation, seizures, severe blood-pressure spikes, or head injury. Early symptoms of cortical blindness may appear suddenly after a stroke, so emergency care can open doors to time‑sensitive treatments. Alongside drug therapy, vision rehabilitation and day‑to‑day adaptations remain important.
In acute ischemic stroke, alteplase or tenecteplase may dissolve a brain clot if given within a strict time window. This can limit further damage that worsens cortical blindness.
Aspirin or clopidogrel helps prevent new clots after an ischemic stroke affecting the visual cortex. First-line medications are those doctors usually try first, based on strong evidence and safety in most people.
Apixaban, rivaroxaban, dabigatran, or warfarin reduce clot risk when the stroke source is the heart (for example, atrial fibrillation). These do not improve current vision loss but lower the chance of another event.
Atorvastatin or rosuvastatin lowers LDL and stabilizes artery plaque. This helps prevent future strokes that could worsen vision.
Genetic influences
For most people, genes are not the direct cause; cortical blindness usually follows an injury or illness that affects the brain’s visual centers. It’s natural to ask whether family history plays a role. In some cases, inherited conditions can increase risk—such as those that alter brain development, affect how brain cells make energy, or raise the chance of stroke—which can involve the back part of the brain that processes sight and lead to cortical blindness or cortical visual impairment. In newborns and children, early symptoms of cortical blindness may prompt doctors to look for a rare underlying genetic or metabolic condition, especially when brain scans show developmental differences. When genetics are involved, the picture can vary within the same family; some relatives may have subtle visual processing challenges while others develop more severe vision loss. If your medical team suspects a hereditary cause, they may suggest genetic testing or counseling to help estimate risk for relatives and to guide follow-up care.
Is Cortical blindness genetic?
Genetics plays a limited role in cortical blindness overall, which most often stems from brain injury or stroke. That said, rare inherited conditions can damage the visual cortex and increase risk. Genetic testing is considered when features suggest a hereditary disorder.
Pharmacogenetics—how genetics influence drug effects
For people living with cortical blindness, genetics can matter in two ways: the root cause and how your body handles medicines used in care. If cortical blindness follows a stroke, blood thinners or clot‑prevention medicines may be used, and common gene differences can affect how strongly some of these drugs work or what dose is safest. When cortical blindness occurs with seizures, migraines, mood symptoms, or sleep problems, gene differences that change drug‑processing speed can influence side effects and benefit with certain seizure medicines, antidepressants, or pain relievers. Some gene types are linked to rare but serious skin reactions with specific seizure medicines, so doctors may avoid those drugs if a risk is found. Alongside your medical history and current medicines, genetic testing can sometimes help fine‑tune dosing or drug choice. While pharmacogenetic testing in cortical blindness care will not restore vision, it may help tailor supportive treatments and reduce trial‑and‑error, especially after stroke or when seizures are part of the picture.
Interactions with other conditions
Cortical blindness often appears alongside other brain conditions, especially after a stroke or a significant head injury. Doctors call it a “comorbidity” when two conditions occur together. When stroke-related problems like weakness or speech changes are present, early symptoms of cortical blindness can be missed or mistaken for attention issues, which can delay vision-specific rehab. Seizures that start in the back of the brain and migraine aura can temporarily worsen visual confusion; some anti-seizure medicines may add fatigue or blurred vision, making day‑to‑day adaptation harder. Conditions that raise stroke risk—high blood pressure, diabetes, and an irregular heartbeat—indirectly interact with cortical blindness by increasing the chance of the brain injury that causes it, so managing these is key. Anxiety and low mood are common with sudden vision loss, and when combined with other neurologic problems, coordinated care with neurology, vision rehab, and mental health support can help people with cortical blindness maintain independence.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden loss of sight after head injuries, high fevers, or difficult births, long before anyone looked closely at the eyes themselves. In some accounts, someone could not see yet could still blink to light or move their eyes normally—details that hinted the problem was not in the eyes, but deeper in the brain’s visual centers.
From early theories to modern research, the story of cortical blindness shows how medicine learned to separate problems of the eye from problems of the brain. Nineteenth‑century clinicians linked wounds to the back of the head with loss of vision, and autopsy studies mapped the “seeing” area to the occipital lobes. Early reports called it “psychic blindness” in some cases, reflecting uncertainty about why people could not recognize what they saw even when their eyes were healthy. Over time, careful bedside exams, wartime neurology, and later brain imaging clarified that cortical blindness arises when both occipital lobes are damaged by stroke, lack of oxygen, infection, trauma, or other causes.
In the mid‑1900s, neurologists described people who appeared unaware of their vision loss, a pattern now known as Anton syndrome, and others who had islands of remaining sight or could sense movement without recognizing shapes. These observations showed that cortical blindness can range from complete loss of vision to partial, fluctuating problems, sometimes with intact pupil responses and normal eye exams. Pediatric cases after birth complications and adult cases after cardiac arrest or severe low blood pressure broadened the picture across ages.
As medical science evolved, electroencephalography and visual evoked potentials offered early ways to test whether visual signals were reaching the brain. The arrival of CT and then MRI in the late twentieth century let clinicians see strokes and other injuries in the visual cortex during life, anchoring stories to clear images. In recent decades, awareness has grown that recovery varies: some people regain useful vision with time and rehabilitation; others live with permanent loss, occasionally developing visual hallucinations (Charles Bonnet phenomenon) because the brain is deprived of normal input.
Advances in intensive care, stroke treatment, and neonatal medicine changed who survived and how often cortical blindness was recognized. Today, the term “cortical” or “cerebral” visual impairment is used more precisely, especially in children, to reflect vision problems from brain pathways rather than the eyes. Understanding this history helps explain why someone may have a normal eye exam yet still struggle to see—the injury lies in the brain’s visual network, not the eye itself.